Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib

J Clin Oncol. 2010 Jul 1;28(19):e312-3. doi: 10.1200/JCO.2009.26.4432. Epub 2010 Jun 1.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenoma, Oxyphilic / drug therapy
  • Adult
  • Black or African American
  • Female
  • Hair / drug effects
  • Hair / pathology
  • Humans
  • Hypopigmentation / chemically induced*
  • Indazoles
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Skin / drug effects
  • Skin / pathology
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • Thyroid Neoplasms / drug therapy

Substances

  • Indazoles
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • pazopanib